Skip to main content
. Author manuscript; available in PMC: 2018 Jun 25.
Published in final edited form as: AIMS Biophys. 2017 Aug 21;4(3):491–527. doi: 10.3934/biophy.2017.3.491

Figure 4.

Figure 4

Timeline of availability for individual representative GPCR crystal structure structures including protein fusion partners. Rho (1F88), ADRB2 (2R4R), ADRB1 (2VT4), A2AR (3EML), TACR1 (2KS9), CXCR4 (3ODU), D3R (3PBL), H1R (3RZE), S1P1 (3V2W), M2R (3UON), CXCR1 (2LNL), M3R (4DAJ), κ-OR (4DJH), μ-OR (4DKL), NOP (4EA3), δ-OR (4EJ4), PAR1 (3VW7), NSTR1 (3ZEV), 5-HT1B (4IAQ), 5-HT2B (4IB4), SMO (4JKV), CRF1R (4K5Y), CCR5 (4MBS) P2Y12 (4NTJ), mGlu5 (4OO9), mGlu1 (4OR2), FFAR1 (4PHU), OX2 (4S0V), P2Y1 (4XNW), HHV-5 US28 (4XT1), AT1R (4YAY), LPA1 (4Z34), OX1 (4ZJ8), M1R (5CXV), M4R (5DSG), GCGR (5EE7), CCR9 (5LWE), ET-B (5GLH), CCR2 (5T1A), CB1 (5TGZ), A1AR (5UEN), AT2R (5UNF).